EU Consumer Health: GSK’s momelotinib wins Orphan Drug Designation from the FDA and EMA for VEXAS syndrome, as the ATLAS phase II/III trial moves ahead for a rare condition with no approved treatments. EU Retail & Consumer Protection: EuroCommerce urges tougher, smarter enforcement of the EU Consumer Protection Cooperation rules to close gaps across the Single Market. Tech & Consumer Impact: Apple says EU iPhone and iPad users will miss out on the new Siri AI rollout for now, blaming unresolved regulator issues under the Digital Markets Act. Energy Costs: A new ranking shows electricity prices vary wildly, with Europe and fuel-importing islands dominating the high-cost end. Pharma Shortages: A continent-wide look at shortages highlights antibiotics, insulin and cancer drugs as recurring pressure points for patients and health systems. Finance & Trading: OKX expands European access to U.S. stock/commodity derivatives via new X-Perp markets, pushing more retail exposure through crypto-linked products. Industrial Supply Chains: WuXi AppTec expands manufacturing across the U.S., Europe and Asia to give drugmakers more regional options under one quality system. EU Policy & Sanctions: The EU widens Iran sanctions to target people and entities that impede lawful transit in the Strait of Hormuz, tightening compliance pressure for shipping and related services. Dermatology Launch: Glenmark launches Winlevi (clascoterone) cream across key European markets for acne vulgaris. Retail Markets: BYD hunts for a pre-existing factory in Southern Europe for its second plant, with Spain flagged as a leading candidate.